ALS Industry Content
Click to explore all of our content related to the 2026 event.
Speaker Interview with Trace Neuroscience
Exclusive interview with Irina Antonijevic, Chief Medical Officer at Trace Neuroscience
Inside the Latest ALS Drug Development Breakthroughs
One of the most significant shifts in the past year has been the diversification of targets beyond historically...
Explore the Agenda
Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of ALS & FTD
Partner With Us
Showcase your solutions, connect with decision makers, and position your company as the go-to provider in neuromuscular and neurodegenerative research
Join Biopharma Experts
Network with pharma, biotech, diagnostics, academia, consortia, and patient voices driving real-world adoption